PELEUS
DEAD

Serial Number

87850414

Owner

ACHILLES THERAPEUTICS UK LIMITED

Attorney

Mark Harrison

Filing Date

Mar 26, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PELEUS Trademark

Serial Number: 87850414 • Registration: 5743057

PELEUS is a trademark filed by ACHILLES THERAPEUTICS UK LIMITED on March 26, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ACHILLES THERAPEUTICS UK LIMITED (7 trademarks)

245 HAMMERSMITH ROAD
LONDON W6 8PW , GB

Entity Type: 24

Achilles Therapeutics Limited (3 trademarks)

Gunnels Wood Road
Stevenage SG12FX

Entity Type: 99

Trademark Details

Filing Date

March 26, 2018

Registration Date

May 7, 2019

Published for Opposition

February 19, 2019

Cancellation Date

November 21, 2025

Goods & Services

Medical and veterinary preparations for therapeutic purposes namely, pharmaceutical and veterinary preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; pharmaceutical products for the diagnosis, prevention and treatment of cancer; pharmaceutical preparations for cancer therapy; antibodies being pharmaceutical preparations for the diagnosis, treatment and prevention of cancer, immune response disorders, genetic conditions, infectious diseases and vascular diseases; vaccines; pharmaceutical preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes

Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies; and research and design relating thereto; industrial analysis and research services in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services involving the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research into cancer evolution and clonal architecture; scientific research in human and animal cell therapy; scientific research into vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; providing software as a service for the identification of clonal neo-antigens; providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; providing a bioinformatics platform featuring computer software for identifying clonal neoantigens

Medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies

Custom manufacture of therapeutic drugs, namely, custom manufacture of cell therapies and cancer therapies

Bioinformatics software for sequence data analysis; computer software platforms for sequence data analysis in the fields of cancer evolution and new cancer therapies, immune response disorders, genetic conditions, infectious diseases and vascular disease

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 21, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 7, 2024 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 4, 2021 ASGN
REGISTERED-PRINCIPAL REGISTER
May 7, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 19, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 30, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 1, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 28, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 28, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 28, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 28, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 24, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 24, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 11, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 11, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 11, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 10, 2018 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 8, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 8, 2018 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2018 NWOS
NEW APPLICATION ENTERED
Mar 29, 2018 NWAP